
|Articles|September 1, 2001
Adhering to caution part of systemic retinoid use
Patients, physicians must be aware of serious toxicity risks
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus
2
The Aesthetic Edge: January 2026
3
Case-Based Perspectives on Biologic Treatment for Hidradenitis Suppurativa
4
Atopia Therapeutics Reports Positive Preclinical Data for ATP-R13 as Disease-Modifying Oral AD Therapy
5










